Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

While most students spend their January break catching up on well-deserved sleep or binge-watching Netflix, 20-year-old Ruby ...